Elekta (OTCMKTS:EKTAY) Stock Price Down 4.7% – Should You Sell?

Shares of Elekta AB (OTCMKTS:EKTAY) dropped 4.7% during trading on Tuesday . The stock traded as low as $5.7150 and last traded at $5.7150. Approximately 716 shares were traded during trading, a decline of 93% from the average daily volume of 10,883 shares. The stock had previously closed at $5.9950.

Analyst Ratings Changes

A number of brokerages have recently weighed in on EKTAY. Zacks Research upgraded Elekta from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 16th. UBS Group started coverage on shares of Elekta in a report on Wednesday, September 3rd. They set a “sell” rating on the stock. Three equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Elekta has a consensus rating of “Reduce”.

Elekta Price Performance

The company has a current ratio of 1.05, a quick ratio of 0.82 and a debt-to-equity ratio of 0.63. The stock has a market capitalization of $2.21 billion, a P/E ratio of 85.73 and a beta of 1.04. The company has a fifty day simple moving average of $5.13 and a two-hundred day simple moving average of $5.07.

Elekta (OTCMKTS:EKTAY) last issued its earnings results on Wednesday, November 26th. The company reported $0.07 earnings per share (EPS) for the quarter. The company had revenue of $427.85 million for the quarter, compared to analyst estimates of $436.91 million. Elekta had a net margin of 1.62% and a return on equity of 12.06%. Sell-side analysts expect that Elekta AB will post 0.36 EPS for the current fiscal year.

About Elekta

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.